0.6331
0.95%
0.0031
Tc Biopharm Holdings Plc Adr (TCBP) Stock Split History
Tc Biopharm Holdings Plc Adr has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on November 21, 2022 with the ratio of 1-for-50, meaning that for 50 shares of TCBP owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on August 05, 2024 on a 1-for-10 basis.
These splits have increased TCBP stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Tc Biopharm Holdings Plc Adr's total market capitalization.
For more detailed information of Tc Biopharm Holdings Plc Adr's stock splits, view the table below:
These splits have increased TCBP stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Tc Biopharm Holdings Plc Adr's total market capitalization.
For more detailed information of Tc Biopharm Holdings Plc Adr's stock splits, view the table below:
TCBP stock split list
Date | Split Ratio |
---|---|
2024-08-05 | 1 - for - 10 |
2023-12-15 | 1 - for - 20 |
2022-11-21 | 1 - for - 50 |
Will Tc Biopharm Holdings Plc Adr Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Tc Biopharm Holdings Plc Adr has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when TCBP stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Tc Biopharm Holdings Plc Adr's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Stock Splits of Industry Leaders
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):